Notice: You are viewing an unstyled version of this page. Are you using a very old browser? If so, please consider upgrading

TOAST clinical trial for babies born with the birth defect oeasophageal atresia

Published on Monday, 01 March 2021 Tweet

Researchers from the NPEU are helping to coordinate a new large-scale study called Treating Oesophageal Atresia to prevent STricture (TOAST). The study will investigate whether antacid medications help or hinder treatment of babies born with oesophageal atresia (OA), a severe birth defect.

For more information, please read the NDPH news article Major new 'Gold Standard' trial aims to help improve treatment for babies born with oesophageal atresia

Updated: Monday, 01 March 2021 09:58 (v4)